A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1992
10/14/1992	EP0508234A2 Beta-lactames
10/14/1992	EP0507872A1 The use of arginine as an immunostimulator
10/14/1992	EP0507867A1 Papillomavirus (hpv63) probe, particularly for the in vitro diagnosis of papillomavirus infections, possibly accompanied by genital neoplasias, and products genetically and immunologically linked to this papillomavirus
10/14/1992	EP0403575B1 Acyl carnitine for the treatment and prevention of virus infections
10/14/1992	EP0368933B1 Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
10/14/1992	EP0208743B1 Polydispersed native pseudomonas-flagella (h)-antigens (fag) and methods for their preparation
10/14/1992	CN1065205A Preventive agent against infectious disease of crustacea
10/14/1992	CN1018648B Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives
10/14/1992	CN1018640B Process for the preparation of compounds for the induction of in vivo and in vitro production of cytokines
10/14/1992	CA2108175A1 Use of guanine derivative or a prodrug thereof in the treatment of hiv-1 infection
10/13/1992	WO1992018125A1 Michellamines useful as antiviral agents, composition and method of treatment
10/13/1992	US5155249 Differentiating neoplastic cells, treating psoriasis, immune or inflammatory diseases
10/13/1992	CA1308719C 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines
10/13/1992	CA1308714C2 Antiviral compounds
10/12/1992	CA2065218A1 Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
10/12/1992	CA2064945A1 .beta.-lactams
10/11/1992	WO1992018621A1 Proteinaceous lipid-containing particles
10/11/1992	WO1992018620A1 Attenuated poliovirus and vaccines thereof
10/11/1992	WO1992018123A2 A method for inhibition of retroviral replication
10/11/1992	CA2108141A1 Attenuated poliovirus and vaccines thereof
10/11/1992	CA2107879A1 Proteinaceous lipid-containing particles
10/11/1992	CA2065674A1 8a-aza-8a-homoerythromycin cyclic iminoethers
10/11/1992	CA2065629A1 .alpha.-methylene-4-¬(phenoxy)methyl\|thiazole-5-acetic acid derivatives; process and intermediates for preparing the same; their use as fungicides; compositions containing them
10/10/1992	CA2065222A1 Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
10/09/1992	WO1992017481A1 Antibiotic carbapenem derivatives
10/09/1992	WO1992017480A1 Antibiotic carbapenem derivatives
10/09/1992	WO1992017195A1 Novel peptide compositions and uses therefor
10/09/1992	CA2107782A1 Antibiotic carbapenem derivatives
10/09/1992	CA2107781A1 Antibiotic carbapenem derivatives
10/09/1992	CA2107674A1 Novel peptide compositions and uses therefor
10/07/1992	EP0507615A1 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
10/07/1992	EP0507604A2 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention
10/07/1992	EP0507595A1 8A-aza-8A-homoerythromycin lactams
10/07/1992	EP0507556A1 Silyl ethers of rapamycin
10/07/1992	EP0507488A1 Inhibitors of HIV-1 reverse transcriptase
10/07/1992	EP0507484A1 A pharmaceutical formulation of aureobasidins
10/07/1992	EP0507337A2 Novel erucyl, brassidyl and nervonyl derivatives
10/07/1992	EP0507224A2 Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
10/07/1992	EP0507179A2 Equine herpes viruses (EHV) containing foreign DNA, process for their preparation and their use as vaccines
10/07/1992	EP0506982A1 1-azabicyclo 3.2.0]hept-2-ene-2-carboxylic acid compounds
10/07/1992	EP0506855A1 Cytokine antibody for the treatment of sepsis
10/07/1992	EP0506830A1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
10/07/1992	EP0506769A1 Pharmaceutical composition for treating or preventing retroviral infections.
10/07/1992	EP0506729A1 Pharmaceutically active oxazole compounds
10/07/1992	EP0493380A4 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/07/1992	EP0316313B1 Process for the preparation of antibiotics 10381b
10/07/1992	CN1065069A Process for preparing erythromycin derivatives
10/07/1992	CN1065065A Process for preparing 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/06/1992	US5153318 Viricides for hepatitis and human t-cell leukemia/lymphoma viruses
10/06/1992	US5153212 For human or veterinary use
10/06/1992	US5153188 Thienamycin antibiotics
10/06/1992	US5153187 1-methylcarbapenem derivatives and process for preparation thereof
10/06/1992	US5153181 Administering a polysaccharides containing sulfate groups
10/06/1992	US5153127 From cultivation of streptomyces or mutants thereof under aerobic conditions for controlling fungus infections in plants
10/06/1992	US5152978 Sulphated vinyl polymers in compositions for treating retroviral infections
10/06/1992	CA2064985A1 8a-aza-8a-homoertyhromycin cyclic lactams
10/06/1992	CA1308358C Antibacterial lyophilized preparation
10/03/1992	WO1992017173A2 Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria
10/03/1992	CA2107078A1 Use of riboflavin in the treatment of hiv-linked diseases, herpes, retinitis pigmentosa and malaria
10/03/1992	CA2063968A1 Pharmaceutical formulation of aureobasidins
10/02/1992	CA2063962A1 Silyl ethers of rapamycin
10/01/1992	WO1992016666A1 N6-(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
10/01/1992	WO1992016636A1 Recombinant virus vectors encoding human papillomavirus proteins
10/01/1992	WO1992016624A1 Monoclonal antibody against lps core
10/01/1992	WO1992016616A1 Malaria recombinant poxvirus vaccine
10/01/1992	WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
10/01/1992	WO1992016521A1 Novel fluorine-containing quinolones and process for their preparation
10/01/1992	WO1992016517A1 Pharmaceutical xanthone derivatives
10/01/1992	WO1992016232A1 Polysaccharide-protein conjugates
10/01/1992	WO1992016231A1 HERPES SIMPLEX VACCINE COMPRISING HSV GLYCOPROTEIN gD AND 3 dEACYLATED MONOPHOSPHORYL LIPID A
10/01/1992	WO1992016201A1 Method for inactivating enveloped viruses and sperm
10/01/1992	CA2106464A1 Malaria recombinant poxvirus vaccine
10/01/1992	CA2106069A1 Recombinant virus vectors encoding human papillomavirus proteins
09/1992
09/30/1992	EP0506651A2 Pharmaceutical preparation based on plasma proteins
09/30/1992	EP0506628A2 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances
09/30/1992	EP0506532A1 Indole derivatives, process for their preparation and medicaments containing them
09/30/1992	EP0506463A2 New compounds, named the "leustroducsins" their preparation and their therapeutic uses
09/30/1992	EP0506326A2 Diequitorially bound beta 1-4 polyuronates and use of same for cytokine stimulation
09/30/1992	EP0506325A1 Guluronic acid polymers and use of same for inhibition of cytokine production
09/30/1992	EP0506300A2 Tacky, hydrophilic gel dressings and products therefrom
09/30/1992	EP0506197A1 Topical preparation containing a suspension of solid lipid particles
09/30/1992	EP0506072A1 Novel azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
09/30/1992	EP0506048A1 Sulfated tocopheryl oligosaccharides and antiviral agents including the same as active ingredients
09/30/1992	EP0505941A2 Peptifluorin and neopeptifluorin
09/30/1992	EP0505908A1 Chimaeric polypeptides
09/30/1992	EP0505817A1 Use of phosphatidylserine and its derivatives for the manufacture of a medicament for the treatment of degenerative pathologies also associated with immune disfunctions
09/30/1992	EP0505735A1 Antibiotic A 40926 ester derivatives
09/30/1992	EP0505400A1 N-substituted naphthalamides, their production and use
09/30/1992	CN1064892A Recombinant virus vectors
09/30/1992	CA2062406A1 Ganglioside gm3 analogs
09/30/1992	CA2062369A1 Thioglycoside analogs of gangliosides
09/29/1992	US5151023 Hepatitis a,b-combined adjuvanted vaccine
09/29/1992	CA2061476A1 Peptifluorin and neopeptifluorin
09/29/1992	CA1308107C Monosulfactams
09/29/1992	CA1308026C Control release composition containing zidovudine
09/28/1992	CA2064126A1 Compounds, named the "leustroducins", their preparation and their therapeutic uses
09/28/1992	CA2063909A1 Inhibitors of hiv-1 reverse transcriptase
09/28/1992	CA2063035A1 Chimaeric antibodies containing the ligand domain of cd4
09/27/1992	WO1992017183A1 Sequential dosing of antifungal and antiinflammatory compositions
09/27/1992	CA2107237A1 Sequential dosing of antifungal and antiinflammatory compositions

1 ... 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 ... 1798